USANA Health Sciences (USNA) Misses Q4 EPS by 7c, FY Guidance Misses Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
USANA Health Sciences Reports Fourth Quarter and Full-Year Financial Results
February 7, 2017 4:15 PM ESTFourth quarter net sales increased 8.7% to $252.9 million, up 12.7% in constant currency Number of active Associates at quarter-end increased 11.9% to 471,000 Fourth quarter EPS decreased 5.4% to $0.871 For the year, net sales increased 9.5% to a record $1.006 billion, up 14.1% in constant currency For the year, EPS increased 11.1% to a record $3.991 Company provides 2017 Outlook
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results... More
